Julie M. Cherrington
Julie M. Cherrington, Ph.D. joined Mirati’s Board of Directors in June 2019. She is an experienced life science executive with extensive insight in bringing drugs into the clinic and through to commercialization. She has been a key contributor to the successful development of multiple FDA-approved products, including SUTENT®, PALLADIA®, VISTIDE®...
Roles at Mirati Therapeutics